3.75 USD
-0.10
2.60%
Updated Apr 1, 3:17 PM EDT
1 day
-2.60%
5 days
-2.60%
1 month
6.53%
3 months
-6.25%
6 months
-49.26%
Year to date
-6.25%
1 year
-63.59%
5 years
-39.22%
10 years
-72.41%
 

About: Braskem SA manufactures and sells chemicals, petrochemicals, fuels, and utilities. The company's geographical segments include Brazil; the United States and Europe and Mexico. It derives a majority of its revenue from Brazil. It produces olefins, such as ethylene, polymer and chemical-grade propylene, butadiene, and butene-1; fuels, such as automotive gasoline, liquefied petroleum gas, or LPG, ethyl tertiary-butyl ether, or ETBE, and methyl tertiary-butyl ether, or MTBE; intermediates, such as cumene and others.

Employees: 8,382

0
Funds holding %
of 7,398 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

40% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 15

0.06% less ownership

Funds ownership: 3.11% [Q3] → 3.05% (-0.06%) [Q4]

5% less funds holding

Funds holding: 63 [Q3] → 60 (-3) [Q4]

19% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 16

48% less capital invested

Capital invested by funds: $79.1M [Q3] → $41.1M (-$38.1M) [Q4]

Research analyst outlook

We haven’t received any recent analyst ratings for BAK.

Financial journalist opinion

Negative
Seeking Alpha
1 day ago
Braskem Q4: Challenging But Opportune Scenario For Patient Investors
Braskem's net revenues fell 14% q/q and 2% y/y in 4Q24 due to reduced petrochemical spreads and lower demand. Despite high leverage, Braskem's $2.4 billion cash ensures debt coverage for the next 47 months, projecting operational cash recovery. Valuation comparison with peers suggests a 19% upside, reinforcing my buy recommendation despite challenging market conditions.
Braskem Q4: Challenging But Opportune Scenario For Patient Investors
Neutral
Seeking Alpha
1 month ago
Braskem S.A. (BAK) Q4 2024 Earnings Conference Call Transcript
Braskem S.A. (NYSE:BAK ) Q4 2024 Earnings Conference Call February 27, 2025 9:00 AM ET Company Participants Rosana Avolio - Investor Relations Manager Roberto Ramos - CEO Felipe Jens - CFO Conference Call Participants Nicolas Barros - Bank of America Henrique Perez - BTG Pactual Pedro Gama - Citi Operator Good morning everyone and thank you for waiting.
Braskem S.A. (BAK) Q4 2024 Earnings Conference Call Transcript
Neutral
PRNewsWire
1 month ago
Braskem reports Recurrent Cash Generation of R$265 million in 4Q24; Recurring EBITDA of US$1.1 billion in 2024 (46% higher than 2023)
SÃO PAULO, Feb. 27, 2025 /PRNewswire/ -- BRASKEM S.A. (B3: BRKM3, BRKM5 and BRKM6; NYSE: BAK; LATIBEX: XBRK) the largest resin producer in the Americas and the world's leading biopolymers producer, presents its 4Q24 Earnings Release.
Braskem reports Recurrent Cash Generation of R$265 million in 4Q24; Recurring EBITDA of US$1.1 billion in 2024 (46% higher than 2023)
Positive
Zacks Investment Research
1 month ago
Has Braskem (BAK) Outpaced Other Oils-Energy Stocks This Year?
Here is how Braskem (BAK) and National Fuel Gas (NFG) have performed compared to their sector so far this year.
Has Braskem (BAK) Outpaced Other Oils-Energy Stocks This Year?
Positive
Zacks Investment Research
2 months ago
Does Braskem (BAK) Have the Potential to Rally 63.29% as Wall Street Analysts Expect?
The mean of analysts' price targets for Braskem (BAK) points to a 63.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Does Braskem (BAK) Have the Potential to Rally 63.29% as Wall Street Analysts Expect?
Positive
Zacks Investment Research
2 months ago
New Strong Buy Stocks for January 28th
PBPB, BBCP, BAK, NVAX and ETON have been added to the Zacks Rank #1 (Strong Buy) List on January 28, 2024.
New Strong Buy Stocks for January 28th
Positive
MarketBeat
2 months ago
Braskem: A Green Investment in the Bioplastics Market
Braskem NYSE: BAK is the largest producer of thermoplastic and bioplastic resins in the Americas, making the stock a compelling investment opportunity for those seeking to align their portfolios with a sustainable future. The company's strategic positioning at the forefront of the developing bioplastics market makes it a top pick for investors prioritizing environmental, social, and governance (ESG) factors, especially given the global shift towards sustainability and the significant transition in the plastics and packaging sectors.
Braskem: A Green Investment in the Bioplastics Market
Positive
Zacks Investment Research
2 months ago
Braskem (BAK) Moves to Strong Buy: Rationale Behind the Upgrade
Braskem (BAK) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Braskem (BAK) Moves to Strong Buy: Rationale Behind the Upgrade
Positive
Zacks Investment Research
2 months ago
Best Momentum Stocks to Buy for January 23rd
BBCP, BAK and KMX made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 23, 2025.
Best Momentum Stocks to Buy for January 23rd
Positive
Zacks Investment Research
2 months ago
New Strong Buy Stocks for January 23rd
BRLT, GTLB, BBCP, BAK and KMX have been added to the Zacks Rank #1 (Strong Buy) List on January 23, 2025.
New Strong Buy Stocks for January 23rd
Charts implemented using Lightweight Charts™